Skip to main content
OncoBeta logoOncoBeta logo

Painless, Non-Invasive
Skin Cancer Therapy

Learn More

Bringing back
Quality of Life

non-invasive
Non-Invasive
painless
Painless
single-session
Single Session

OncoBeta has developed the world-first epidermal radioisotope therapy for the effective treatment of non-melanoma skin cancers, including basal cell carcinoma (BCC) and squamous cell carcinoma (SCC).

OncoBeta offers a groundbreaking treatment option for patients with non-melanoma skin cancer (NMSC) – the world’s most prevalent cancer. Rhenium-SCT® utilizes the Beta emitter radioisotope Rhenium-188 to painlessly treat NMSC, without the need for invasive surgery, therefore providing positive aesthetic outcomes. In most cases, treatment with Rhenium-SCT only requires one quick, personalized treatment.

OncoBeta is committed to changing the way people think about NMSC treatment, leading the field in innovation, and improving patients’ quality of life.

Where to get treated?

Have you been diagnosed with non-melanoma skin cancer?
Find a treatment location near you or utilize the referral program below.

Find a treatment center

map of the world with locations providing the rhenium-sct

Our Products

OncoBeta is ISO 13485 & CE certified medical device company and has received regulatory approval from the Australian Therapeutic Goods Administration (TGA).

rhenium sct treatment

Rhenium-SCT®

Painless Non-Invasive Non Melanoma Skin Cancer Therapy

wolfram rhenium generators

188W/188Re Generators

Production of high-energy beta emitting 188Re
 

Rhenium-SCT®

non-invasive
Non-Invasive
painless
Painless
aesthetic
Aesthetic

The Rhenium-SCT (Skin Cancer Therapy) is a specialized state-of-the-art brachytherapy utilizing the radioisotope Rhenium-188, a beta-emitter which in this case is used for the treatment of basal and squamous cell carcinomas of the skin.

Learn More
comparison of ears after treatment
example of Re-188 compound applied to forehead
Learn More

188W/188Re Generator

Production of high-energy beta emitting 188Re

Wolfram Rhenium Generator

Various sizes available

up to 150GBq (4Ci) 188W

High activity concentration

up to 9GBq/ml

Variable elution volume

Elution volume of 5-14 ml (partial elution for small volumes)

Low breakthrough

188W < 0.01 % in relation to 188Re at calibration time

Learn More

Who we are

OncoBeta GmbH is a pioneer in the radioisotope sector, presently offering an innovative Skin Cancer Therapy targeting non-melanoma skin cancers and producing Tungsten (Wolfram)-188/Rhenium-188 (W/Re-188) Generators for commercial use.

About Us